Bora Pharmaceuticals Laboratories Inc. sell "Liquid Contract Manufacturing - solutions, suspensions, and nasal sprays"

With its acquisition of the GSK Mississauga site, Bora Pharmaceuticals gains a third location with expanded capabilities across oral solid dosage, sachets, liquids (solutions, suspensions, and nasal sprays), and semi-solids (creams, ointments, gels, pastes). The highly automated Mississauga site improves cost-effectiveness while strictly following Bora's Quality Management System and current GMP, offering solution, suspension, and nasal spray manufacturing, solvent handling, work with potent compounds, hormones, and steroids, formulation, process, and analytical development, fully serialized packaging, and stability testing and storage.